Clinical Trial Update: Nasal Gel for the Prevention and Treatment of Nausea Associated With Motion Sickness [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for a nasal gel aimed at prevention and treatment of nausea associated with motion sickness.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Motion Sickness

Snippet

Sponsor: Repurposed Therapeutics, Inc. | Conditions: Motion Sickness | Phase 3 | Status: COMPLETED